Intestinal Research

Brief Communication

IBD

The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis: Jae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, John R Fullarton, Edouard Louis, Fernando Magro, Juan Ricardo Marquez, Alexander R Moschen, Neeraj Narula, Grazyna Rydzewska, Axel U Dignass, Simon PL Travis; Intest Res 2023;21(1):161-167. Published online April 18, 2022; DOI: https://doi.org/10.5217/ir.2022.00006

PDF Supplementary Material PubReader ePub

Citations

Citations to this article as recorded by

New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases
Jihye Park, I. Seul Park, Ji Hyung Kim, Jung Hyun Ji, Soo Jung Park, Jae Jun Park, Tae Il Kim, Seung Won Kim, Jae Hee Cheon
Therapeutic Advances in Gastroenterology.2024;[Epub] CrossRef

4,804 View
533 Download
1 Web of Science
1 Crossref

Original Article

IBD

IBD2020 global forum: results of an international patient survey on quality of care: Peter Irving, Johan Burisch, Richard Driscoll, Mats Olsson, John R Fullarton, Barry S Rodgers-Gray, Simon PL Travis; Intest Res 2018;16(4):537-545. Published online October 10, 2018; DOI: https://doi.org/10.5217/ir.2018.00041

Abstract PDF Supplementary Material PubReader ePub

Background/Aims
IBD2020 is a global forum for standards of care in inflammatory bowel disease (IBD). The aim of the IBD2020 survey was to identify and describe variations in quality care of IBD.
Methods
Patients with IBD from Finland, Italy, France, Canada, Germany, UK, Spain and Sweden were surveyed during 2013 to 2014, covering: disease characteristics; impact on life and work; organization and perceived quality of care.
Results
Seven thousand five hundred and seven patients participated (median age, 39 years [range, 10–103 years]; 2,354 male [31.4%]), including 4,097 (54.6%) with Crohn’s disease (CD) and 3,410 (45.4%) with ulcerative colitis (UC). Median time from symptom onset to diagnosis was 1 year for both CD (range, 0–47 years) and UC (range, 0–46 years), with no clear evidence of improvement in diagnostic delay over the preceding 24 years. Half of the patients (3,429; 50.0%) rated their care as “excellent” or “very good,” with similar results for CD and UC across countries. Five factors were significantly (P<0.01) associated with perceived good quality of care: quality of specialist communication; review consultation being long enough; failure to share information; no access to a dietician; speed of advice.
Conclusions
The IBD2020 survey has highlighted areas related to quality of care of IBD from the patients’ perspective, with scope for improvement.

Citations

Citations to this article as recorded by

Children and Young Adults With Inflammatory Bowel Disease Have an Increased Incidence and Risk of Developing Mental Health Conditions: A UK Population-Based Cohort Study
Rachel Cooney, Daniel Tang, Kevin Barrett, Richard K Russell
Inflammatory Bowel Diseases.2024; 30(8): 1264. CrossRef
Impact of mental health comorbidity in children and young adults with inflammatory bowel disease: a UK population-based cohort study
Rachel Cooney, Kevin Barrett, Richard K Russell
BMJ Open.2024; 14(2): e080408. CrossRef
Sources of diagnostic delay for people with Crohn’s disease and ulcerative colitis: Qualitative research study
Valérie Pittet
PLOS ONE.2024; 19(6): e0301672. CrossRef
Systematic review with meta‐analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease
Nishani Jayasooriya, Samantha Baillie, Jonathan Blackwell, Alex Bottle, Irene Petersen, Hanna Creese, Sonia Saxena, Richard C. Pollok
Alimentary Pharmacology & Therapeutics.2023; 57(6): 635. CrossRef
Diagnostic delay in adult inflammatory bowel disease: A systematic review
Eleanor Cross, Benjamin Saunders, Adam D. Farmer, James A. Prior
Indian Journal of Gastroenterology.2023; 42(1): 40. CrossRef
The Experiences of Older Adults Living With Inflammatory Bowel Disease
Noelle Rohatinsky, Brooke Russell, Kevin B. Read
Gastroenterology Nursing.2023; 46(4): 296. CrossRef
Unmet Challenges in Patients with Crohn’s Disease
Katharina M Scheurlen, Mary A Parks, Anne Macleod, Susan Galandiuk
Journal of Clinical Medicine.2023; 12(17): 5595. CrossRef
The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care
Holly Mathias, Noelle Rohatinsky, Sanjay K Murthy, Kerri Novak, M Ellen Kuenzig, Geoffrey C Nguyen, Sharyle Fowler, Eric I Benchimol, Stephanie Coward, Gilaad G Kaplan, Joseph W Windsor, Charles N Bernstein, Laura E Targownik, Juan-Nicolás Peña-Sánchez, K
Journal of the Canadian Association of Gastroenterology.2023; 6(Supplement): S111. CrossRef
Inflammatory bowel diseases: Transformation of representations. A review
Igor V. Maev, Igor G. Bakulin, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva
Terapevticheskii arkhiv.2023; 95(12): 1064. CrossRef
Early Diagnosis, Early Stratification, and Early Intervention to Deliver Precision Medicine in IBD
Nurulamin M Noor, Paula Sousa, Stéphane Paul, Xavier Roblin
Inflammatory Bowel Diseases.2022; 28(8): 1254. CrossRef
Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis
Axel U. Dignass, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, Jae Hee Cheon, John R. Fullarton, Edouard Louis, Fernando Magro, Juan Ricardo Marquez, Alexander R. Moschen, Neeraj Narula, Grazyna Rydzewska, Simon P. L. Travis
Scandinavian Journal of Gastroenterology.2022; 57(4): 424. CrossRef
Inflammatory bowel disease patient‐reported quality assessment should drive service improvement: a national survey of UK IBD units and patients
A. Barney Hawthorne, Jackie Glatter, Jonathan Blackwell, Rachel Ainley, Ian Arnott, Kevin J. Barrett, Graham Bell, Matthew J. Brookes, Melissa Fletcher, Rafeeq Muhammed, Alan M. Nevill, Jonathan Segal, Christian P. Selinger, Anja St. Clair Jones, Lisa You
Alimentary Pharmacology & Therapeutics.2022; 56(4): 625. CrossRef
Multicriteria Decision Analysis for Updating of Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units in Spain
Xavier Calvet, Julián Panés, Javier Gallardo-Escudero, Alberto de la Cuadra-Grande, Elena Bartolomé, Laura Marín, Fernando de la Portilla, Ester Navarro-Correal, Ana Gutiérrez, Pilar Nos, Ruth Serrano, Miguel Ángel Casado, Manuel Barreiro-de Acosta, Pilar
Journal of Crohn's and Colitis.2022; 16(11): 1663. CrossRef
Patient-reported Outcomes: the ICHOM Standard Set for Inflammatory Bowel Disease in Real-life Practice Helps Quantify Deficits in Current Care
Darren Wong, Lawrence Matini, Andrey Kormilitzin, Ramona Kantschuster, Daniel Martin Simadibrata, Sara Lyden, Jean Wilson, Oliver A Brain, Rebecca Palmer, Tim Ambrose, Jack Satsangi, Matthew South, John Geddes, Keith Bodger, Simon P L Travis, Alissa Walsh
Journal of Crohn's and Colitis.2022; 16(12): 1874. CrossRef
Quality of care in patients with inflammatory bowel disease from a public health center in Brazil
Debora Mayumi Takamune, Giovana Signorelli Astolfi Cury, Giulia Ferrás, Giedre Soares Prates Herrerias, Adriana Rivera, Jaqueline Ribeiro Barros, Julio Pinheiro Baima, Rogerio Saad-Hossne, Ligia Yukie Sassaki
World Journal of Clinical Cases.2022; 10(33): 12184. CrossRef
Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians
David T Rubin, Ailsa Hart, Remo Panaccione, Alessandro Armuzzi, Ulla Suvanto, J Jasper Deuring, John Woolcott, Joseph C Cappelleri, Kathy Steinberg, Laura Wingate, Stefan Schreiber
Inflammatory Bowel Diseases.2021; 27(7): 1096. CrossRef
The new frontier: Certifying quality standards in the inflammatory bowel disease care
Gionata Fiorino, Silvio Danese
United European Gastroenterology Journal.2021; 9(7): 745. CrossRef
Consensus standards of healthcare for adults and children with inflammatory bowel disease in the UK
Rukshana Kapasi, Jackie Glatter, Christopher A Lamb, Austin G Acheson, Charles Andrews, Ian D Arnott, Kevin J Barrett, Graham Bell, Guaraang Bhatnagar, Stuart Bloom, Matthew James Brookes, Steven R Brown, Nicola Burch, Andy Burman, Kay Crook, JR Fraser Cu
Frontline Gastroenterology.2020; 11(3): 178. CrossRef
Quality of Care Standards in Inflammatory Bowel Diseases: a European Crohn’s and Colitis Organisation [ECCO] Position Paper
Gionata Fiorino, Theodore Lytras, Lisa Younge, Catarina Fidalgo, Sofie Coenen, Maria Chaparro, Mariangela Allocca, Ian Arnott, Peter Bossuyt, Johan Burisch, Marjo Campmans-Kuijpers, Lissy de Ridder, Axel Dignass, Ciara Drohan, Roger Feakins, Daniela Gilar
Journal of Crohn's and Colitis.2020; 14(8): 1037. CrossRef
Mejora de la atención al paciente con enfermedad inflamatoria intestinal: Proyecto KOAN
Jordi Guardiola, Laura Marín, Javier P. Gisbert, Fernando Gomollón, Jordi Cohen, Carmen Conde
Economía de la Salud.2019;[Epub] CrossRef

8,530 View
200 Download
19 Web of Science
20 Crossref

First
Prev
Page of 1
Next
Last

Search